SKI Market

Indian Indices

Sensex

82,626.76 -1,048.16
( -1.25%)

Global Indices

Nasdaq

49,514.94 41.95
(0.08%)

Dow Jones

6,856.39 2.63
(0.04%)

Hang Seng

57,040.53 -599.31
(-1.04%)

Nikkei 225

10,448.94 46.50
(0.45%)

Forex

USD-INR

90.59 -0.07
(-0.07%)

EUR-INR

107.56 -0.26
(-0.24%)

GBP-INR

123.48 -0.32
(-0.26%)

JPY-INR

0.59 0.00
(0.20%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Rajnish Wellness Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

541601

INE685Z01033

1.074797

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

48.74

EPS(TTM)

Face Value()

Div & Yield %

Back

Nath Bio-Genes (India) consolidated net profit rises 147.75% in the September 2025 quarter

Nov 15,2025

Net profit of Nath Bio-Genes (India) rose 147.75% to Rs 2.75 crore in the quarter ended September 2025 as against Rs 1.11 crore during the previous quarter ended September 2024. Sales rose 36.22% to Rs 43.85 crore in the quarter ended September 2025 as against Rs 32.19 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	43.85	32.19	36
OPM %	13.91	14.94	-
PBDT	4.38	1.91	129
PBT	3.39	1.09	211
NP	2.75	1.11	148

82,626.76 -1,048.16 ( -1.25%)

49,514.94 41.95 (0.08%)

6,856.39 2.63 (0.04%)

57,040.53 -599.31 (-1.04%)

10,448.94 46.50 (0.45%)

90.59 -0.07 (-0.07%)

107.56 -0.26 (-0.24%)

123.48 -0.32 (-0.26%)

0.59 0.00 (0.20%)